Epidiolex (Cannabidiol)

Epidiolex (Cannabidiol)

Epidiolex

Cannabidiol

Oral Solution: 100 mg/mL

GW Pharmaceuticals plc.

Medical Use

Epidiolex is prescribed for managing seizures in patients aged 12 months and older who have Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous sclerosis complex.

Recommended Dosage:

  • -Before Treatment: Check serum transaminases (ALT and AST) and total bilirubin levels.

For Seizures Associated with Lennox-Gastaut Syndrome or Dravet Syndrome:

  • -Initial Dose: 2.5 mg/kg orally twice daily (5 mg/kg/day).
  • -After 7 Days: Increase to a maintenance dose of 5 mg/kg twice daily (10 mg/kg/day).
  • -Maximum Dose: Can be increased up to 10 mg/kg twice daily (20 mg/kg/day) based on clinical response and tolerability.

For Seizures Associated with Tuberous Sclerosis Complex (TSC):

  • -Initial Dose: 2.5 mg/kg orally twice daily (5 mg/kg/day).
  • -Weekly Increments: Increase by 2.5 mg/kg twice daily (5 mg/kg/day) to a maintenance dose of 12.5 mg/kg twice daily (25 mg/kg/day), as tolerated.
  • -Rapid Titration: If needed, increase dosage no more frequently than every other day to reach 25 mg/kg/day.

Note: The effectiveness of doses below 12.5 mg/kg twice daily has not been evaluated for TSC.

Patients with Hepatic Impairment:

  • -Dose Adjustment: Required for moderate (Child-Pugh B) or severe (Child-Pugh C) hepatic impairment.